Clinical trial
Second-line Switch to Dolutegravir Study
NCT04229290
Study timeline
Study start (actual)2020-02-12Date precision: day
Registry last updated2022-01-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV-1-infectionunresolved
Interventions
DolutegravirDRUG · verified · RxNorm: dolutegravir
Sponsors & collaborators
University of Nairobilead sponsor
ViiV Healthcarecollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04229290 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.